Get the Daily Brief
Latest Biotech News
Innovative Diagnostics and AI-Driven Platforms Secure Funding to Accelerate Development
Goodpath secured $18 million in Series A funding to advance its virtual care platform for chronic disease management, led by MassMutual Ventures. Penguin Ai raised nearly $30 million to automate...
Alzheimer’s Disease Research Links Molecular Mechanisms to Disease Pathogenesis
New findings identify familial Alzheimer's mutations in the SORLA receptor as disruptors of neurotrophic exosome release, reducing cell-to-cell messaging critical for brain health and advancing...
Sustainable Biotech Innovations Harness Natural By-Products and Materials
Scientists report novel biotechnological applications leveraging natural resources and industrial by-products for sustainability. Examples include transforming grape and olive waste into...
Soil Metagenomics Unlocks New Antibiotics: Long-Read Sequencing Advances Natural Product Discovery
Researchers at Rockefeller University have employed terabase-scale long-read sequencing to mine soil metagenomes, unveiling hundreds of novel bacterial genomes and new antibiotic candidates. This...
Biopharma Fundraising and Market Dynamics: Lila Sciences Eyeing $300M Series A
Lila Sciences is reportedly nearing a Series A funding round of $300 million or more, aiming to build autonomous scientific AI capabilities. This huge capital raise highlights growing investor...
Alzheimer’s and Neurodegenerative Research Reveal New Targets and Mechanisms
New studies deepen understanding of Alzheimer’s pathology and potential therapies. Researchers from Aarhus University identified mutant SORLA protein defects impairing neurotrophic exosome...
Advances in Cancer Treatment: Immune Checkpoints and Anticancer Peptides
Cutting-edge research highlights new therapeutic avenues in oncology. A study revealed Galectin-9’s expression on leukemia stem cells predicts prognosis in acute lymphoblastic leukemia,...
Partnerships and Technology Integration Accelerate Sequencing and Informatics
Ultima Genomics and Sapio Sciences announced a strategic partnership to integrate Sapio's AI-powered lab informatics with Ultima's high-throughput, low-cost sequencing platform. This alliance aims...
Biopharma Industry Adjusts to UK Investment Changes Amid Uncertainty
Pharmaceutical giants AstraZeneca and Eli Lilly have paused or reconsidered significant UK investments amid industry headwinds. AstraZeneca halted a $271 million Cambridge research site expansion,...
New Diagnostic and Therapeutic Developments in Rare and Neurological Diseases
Acadia Pharmaceuticals published real-world data from the LOTUS study demonstrating Daybue® (trofinetide) benefits in Rett syndrome symptom management under routine care. Ionis Pharmaceuticals...
Breakthroughs in Cancer Drug Development and Market Activities
Avidity Biosciences reported positive early to mid-stage clinical data for del-zota in Duchenne muscular dystrophy, showing reversal of disease progression and functional improvements. The company...
Advancements in Lab Technologies and Connectivity Tools
Eppendorf launched the VisioNize box 2, a next-generation hardware solution to enhance laboratory device connectivity, monitoring, and management. Complementing its cloud-based VisioNize Lab...
FDA and Regulatory Updates Impacting Biotech and Vaccine Oversight
The FDA’s top drug regulator denied reports suggesting a move to abandon certain advisory committee meetings that review contentious drug applications. Concurrently, FDA officials plan to present...
Avidity Biosciences Reverses Duchenne Progression with Antibody Therapy
Avidity Biosciences released promising early and midstage Phase I/II data for del-zota, an antibody-oligonucleotide conjugate targeting Duchenne muscular dystrophy. Treated patients showed...
Remynd’s REM-127 Shows Cognitive Gains in Alzheimer’s Phase IIa
Remynd NV reported positive results from its Phase IIa trial of REM-127, a novel Alzheimer’s candidate that targets calcium homeostasis disruption caused by pathological tau. The...
FDA Official Joins Eli Lilly, Novo Nordisk Names New Research VP Amid Layoffs
Following recent industry shifts, a former senior cell and gene therapy regulator from the FDA has joined Eli Lilly in a strategic policy role focused on the same therapeutic area. Simultaneously,...
MGI Launches T7+ Sequencer with Breakthrough Throughput and Speed
MGI has introduced the T7+ high-throughput sequencer building on its successful DNBSEQ-T7 platform. The new instrument can generate over 14TB of data in 24 hours, doubling throughput and reducing...
Bioinformatics and AI Drive New CRISPR Diagnostic Platform at VedaBio
VedaBio has secured CRISPR diagnostic intellectual property rights from Mammoth Biosciences to advance its amplification-free syndromic point-of-care molecular diagnostic platform. Leveraging a...
Untapped Soil Microbiome Yields Novel Antibiotics via Long-Read Sequencing
Researchers at Rockefeller University harnessed terabase-scale long-read sequencing of soil metagenomes to recover hundreds of previously unknown bacterial genomes and discover new antibiotic...
Biopharma Financing Trends Show Mixed Biosimilar Adoption Despite Huge Savings
A recent report reveals FDA-approved biosimilars have generated $56.2 billion in savings since 2015 but face adoption challenges due to payer practices and pipeline gaps. Biosimilars hold dominant...